AL-002

N/A

Report date: 2024/05/11 18:33:40

Base Information

Drug NameAL-002
Drug Alias NameAL-002AL-002aAL-002-aAL-002c
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTriggering receptor expressed on myeloid cells 2 stimulants
TargetsTriggering receptor expressed on myeloid cells 2
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[12] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlector IncAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlector Inc
Inactive CompaniesAbbvie Inc
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A